preclinical

Open Access
⁵²Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study
ZITA KÉPES, JUDIT P. SZABÓ, IBOLYA KÁLMÁN-SZABÓ, TAMÁS SASS, REGINA ESZE, GÁBOR OPPOSITS, ISTVÁN JÓSZAI, DEZSŐ SZIKRA, FERENC FENYVESI, ISTVÁN HAJDU and GYÖRGY TRENCSÉNYI

In Vivo November 2024, 38 (6) 2591-2600; DOI: https://doi.org/10.21873/invivo.13735
Open Access
Acute Myelomonoblastic Leukemia (My1/De): A Preclinical Rat Model
VIKTÓRIA ARATÓ, ZITA KÉPES, JUDIT P. SZABÓ, GERGELY FARKASINSZKY, TAMÁS SASS, NOÉMI DÉNES, ADRIENN KIS, GÁBOR OPPOSITS, ISTVÁN JÓSZAI, FERENC KRISZTIÁN KÁLMÁN, ISTVÁN HAJDU, GYÖRGY TRENCSÉNYI and ISTVÁN KERTÉSZ

In Vivo May 2024, 38 (3) 1064-1073; DOI: https://doi.org/10.21873/invivo.13540
Open Access
Concomitant [¹⁸F]F-FAZA and [¹⁸F]F-FDG Imaging of Gynecological Cancer Xenografts: Insight into Tumor Hypoxia
ZITA KEPES, EVA HEGEDUS, TAMAS SASS, CSABA CSIKOS, JUDIT P. SZABO, VIKTORIA SZUGYICZKI, ISTVÁN HAJDU, ISTVAN KERTESZ, GABOR OPPOSITS, JOZSEF IMREK, LASZLO BALKAY, FERENC KRISZTIÁN KALMAN and GYORGY TRENCSENYI

In Vivo March 2024, 38 (2) 574-586; DOI: https://doi.org/10.21873/invivo.13476

Main menu